170 related articles for article (PubMed ID: 35290409)
1. High RRM2 expression has poor prognosis in specific types of breast cancer.
Shi SC; Zhang Y; Wang T
PLoS One; 2022; 17(3):e0265195. PubMed ID: 35290409
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
4. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
5. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.
Zhang H; Liu X; Warden CD; Huang Y; Loera S; Xue L; Zhang S; Chu P; Zheng S; Yen Y
BMC Cancer; 2014 Sep; 14():664. PubMed ID: 25213022
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract][Full Text] [Related]
8. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
10. Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.
Putluri N; Maity S; Kommagani R; Creighton CJ; Putluri V; Chen F; Nanda S; Bhowmik SK; Terunuma A; Dorsey T; Nardone A; Fu X; Shaw C; Sarkar TR; Schiff R; Lydon JP; O'Malley BW; Ambs S; Das GM; Michailidis G; Sreekumar A
Neoplasia; 2014 May; 16(5):390-402. PubMed ID: 25016594
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
12. RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance.
Abdel-Rahman MA; Mahfouz M; Habashy HO
Diagn Pathol; 2022 Jan; 17(1):1. PubMed ID: 34986845
[TBL] [Abstract][Full Text] [Related]
13. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
14. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
15. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
Zhao Y; Wang W; Li J; Du J; Xie Q; Wang M; Liu Z; Huo X; Zhao F; Ren D; Zhao J; Shen G
PLoS One; 2023; 18(11):e0263710. PubMed ID: 38032902
[TBL] [Abstract][Full Text] [Related]
17. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.
Al-Mulla F; Marafie M; Zea Tan T; Paul Thiery J
J Cell Biochem; 2014 Mar; 115(3):488-97. PubMed ID: 24123286
[TBL] [Abstract][Full Text] [Related]
18. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
19. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
20. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
